Annual All-Cause Healthcare Costs Among Influenza Patients With and Without Influenza-Related Complications : Analysis of a United States Managed Care Database.

Related Articles

Annual All-Cause Healthcare Costs Among Influenza Patients With and Without Influenza-Related Complications : Analysis of a United States Managed Care Database.

Appl Health Econ Health Policy. 2013 Mar 26;

Authors: Karve S, Misurski D, Herrera-Taracena G, Davis KL

Abstract
BACKGROUND: Several studies have reported that patients with influenza have a high risk of developing complications such as secondary infections, exacerbation of cardiovascular conditions and asthma. However, limited data exists on the healthcare cost burden for influenza patients with and without influenza-related complications. OBJECTIVE: We compared healthcare utilization and costs among influenza patients with related complications versus patients without complications. METHODS: In this retrospective database analysis (LifeLink database: 1998-2009) of a US managed care database, we selected patients diagnosed with influenza during influenza seasons and categorized them as complicated or uncomplicated based on the presence or absence of a diagnosis for a related complication in the year following their influenza diagnosis. Multivariable regression analyses were conducted to compare all-cause utilization and costs (adjusted to 2009 US dollars) between the two groups. RESULTS: We identified 54,469 patients of which ~65 % had evidence for at least one complication. Patients with complicated influenza had a 1.5-fold higher rate of inpatient utilization compared with uncomplicated cases (p < 0.001). Significantly higher covariate-adjusted predicted mean annual costs were also observed among complicated influenza patients across all care (p-values <0.001 for all comparisons). CONCLUSION: Healthcare costs were twice as high among influenza patients with complications versus those without, with inpatient and outpatient services being the primary cost drivers. Now with the universal recommendation for seasonal influenza vaccination for all individuals ?6 months of age, improvement in coverage rates may help reduce the healthcare utilization and costs associated with influenza and associated complications.

PMID: 23529713 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Health Watch: Promising ‘Combo Inhaler’ For Asthma Patients – CBS Local

Health Watch: Promising 'Combo Inhaler' For Asthma Patients
CBS Local
MINNEAPOLIS (WCCO) — Nine people die from asthma each day in the U.S. Now, a new study looks at patients who have trouble controlling their condition and suggests possibly changing the way doctors treat them. Currently, many asthma patients have
Study suggests new treatment methods for asthma sufferersWNCT
NZ tech leads in treatment of asthmaNew Zealand Herald
Studies support combined prevention and rescue asthma inhalerNursing Times

all 5 news articles »

View full post on asthma – Google News

Every breath tells a story for asthma patients – WFAA


WFAA

Every breath tells a story for asthma patients
WFAA
A machine in the office uses fractional exhaled nitric oxide (FeNO) to measure airway inflammation, the major cause of asthma. The amount of nitric oxide in exhaled breath shows if airways are inflamed. "I think it's huge," said Dr. Rene Leon, an
Nitric Oxide Measure Lower in Younger KidsMedPage Today

all 2 news articles »

View full post on asthma – Google News

Asthma patients don’t have to be alone and suffer/help is there: Mike Holzheimer – Plain Dealer (blog)

Asthma patients don't have to be alone and suffer/help is there: Mike Holzheimer
Plain Dealer (blog)
Again, I hope these words will be an inspiration for adults and children who suffer with asthma. I have known such suffering throughout my lifetime. However, had it not been for one man, and his medical talents, my breathing difficulties would easily

View full post on asthma – Google News

Drug to Treat Asthma Could Relieve Hives Patients of a Chronic Itch, Study Says – New York Times


NBCNews.com (blog)

Drug to Treat Asthma Could Relieve Hives Patients of a Chronic Itch, Study Says
New York Times
An asthma drug has shown promise in relieving itchiness for patients with chronic hives who do not get relief from traditional antihistamine treatment. The drug, omalizumab, known by its brand name, Xolair, is a monoclonal antibody approved to treat
Asthma drug can ease agony of constant itch, tooNBCNews.com (blog)
Asthma Drug Found Highly Effective in Treating Chronic, Severe Hives and ItchScience Daily (press release)
Asthma Drug Curbs Chronic HivesMedPage Today
The Inquisitr –Doctor Tipster –Medscape
all 11 news articles »

View full post on asthma – Google News

Asthma Drug Could Relieve Hives Patients of Itch That Won’t Go Away, Study Says – New York Times


NBCNews.com (blog)

Asthma Drug Could Relieve Hives Patients of Itch That Won't Go Away, Study Says
New York Times
An asthma drug has shown promise in relieving itchiness for patients with chronic hives who do not get relief from traditional antihistamine treatment. The drug, omalizumab, known by its brand name, Xolair, is a monoclonal antibody approved to treat
Asthma drug can ease agony of constant itch, tooNBCNews.com (blog)
Asthma Drug Found Highly Effective in Treating Chronic, Severe Hives and ItchScience Daily (press release)
Asthma Drug Curbs Chronic HivesMedPage Today
The Inquisitr –Doctor Tipster –Medscape
all 9 news articles »

View full post on asthma – Google News